(Q47765940)

5 February 2018

title

The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis (English)

1 reference

5 February 2018

1 reference

1 reference

Christian Brun-Buisson

1

object named as

Christian Brun-Buisson

1 reference

5 February 2018

author name string

Françoise Roudot-Thoraval

2

1 reference

5 February 2018

Emmanuelle Girou

3

1 reference

5 February 2018

Catherine Grenier-Sennelier

4

1 reference

5 February 2018

Isabelle Durand-Zaleski

5

1 reference

5 February 2018

publication date

10 July 2003

1 reference

5 February 2018

published in

Intensive Care Medicine

1 reference

5 February 2018

volume

29

1 reference

5 February 2018

issue

9

1 reference

5 February 2018

page(s)

1464-1471

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s00134-003-1877-x

exact match

0 references

cites work

Evaluation of Definitions for Sepsis

1 reference

12 December 2020

Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality

1 reference

12 December 2020

Research without billing data. Econometric estimation of patient-specific costs

1 reference

12 December 2020

Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group

1 reference

12 December 2020

Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit

1 reference

12 December 2020

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis

1 reference

12 December 2020

Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients

1 reference

12 December 2020

Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients

1 reference

12 December 2020

The economic impact of HA-1A (Centoxin) against endotoxin

1 reference

12 December 2020

The influence of clinical study design on cost-effectiveness projections for the treatment of gram-negative sepsis with human anti-endotoxin antibody

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

A model to compute the medical cost of patients in intensive care

1 reference

12 December 2020

Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission.

1 reference

12 December 2020

Predicting inpatient costs with admitting clinical data

1 reference

12 December 2020

Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent

1 reference

12 December 2020

An economic evaluation of activated protein C treatment for severe sepsis

1 reference

12 December 2020

Estimation of direct cost and resource allocation in intensive care: correlation with Omega system.

1 reference

12 December 2020

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

12 December 2020

Epidemiology of sepsis syndrome in 8 academic medical centers

1 reference

12 December 2020

Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients

1 reference

12 December 2020

How should cost data in pragmatic randomised trials be analysed?

1 reference

12 December 2020

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

1 reference

12 December 2020

Cost-effectiveness of HA-1A treatment for patients with sepsis

1 reference

12 December 2020

Costs, severity of illness and outcome in intensive care.

1 reference

12 December 2020

Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients

1 reference

12 December 2020

10.1007/S00134-003-1877-X

Identifiers

DOI

1 reference

5 February 2018

release_lwkyfpta2fa4xcbeqit5ex3d5a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lwkyfpta2fa4xcbeqit5ex3d5a

24 November 2022

mapped directly with Wikidata item

1 reference

5 February 2018